Skip to content
← Renal Cell Cancer

HEALTH PROFESSIONAL · SOURCE READING

Treatment options for patients with T3b, N0, M0 disease

Source: Renal Cell Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Stage III Renal Cell Cancer / Treatment Options for Stage III Renal Cell Cancer

Radical resection is the accepted, often curative therapy for patients with this stage of renal cell cancer. The operation includes removal of the kidney, adrenal gland, perirenal fat, and Gerota's fascia, with or without a regional lymph node dissection.[11] Lymphadenectomy is commonly used, but its effectiveness has not been definitively proven. Surgery is extended to remove the entire renal vein and caval thrombus and a portion of the vena cava as necessary.[1] EBRT has been given before or after nephrectomy, without conclusive evidence that it improves survival compared with the results of surgery alone. However, it may benefit selected patients with more extensive tumors.

Source links and citations

In patients with stage T3b neoplasms who manifest concurrent or subsequent renal cell cancer in the contralateral kidney, a partial nephrectomy, when technically feasible, may be a preferred alternative to bilateral nephrectomy with dialysis or transplant.[12-14]

Source links and citations

In patients who are not candidates for surgery, arterial embolization can provide palliation.

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice